Velarion Records
Free. Unsubscribe any time.

RECURSION PHARMACEUTICALS, INC. (RXRX)

RECURSION PHARMACEUTICALS, INC. filed 42 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 46 transactions and 3,006,560 shares. None carries the SEC's AFF10B5ONE flag; all 42 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in RECURSION PHARMACEUTICALS, INC. 46

Adoption dates in RECURSION PHARMACEUTICALS, INC. 7

Results prints in RECURSION PHARMACEUTICALS, INC. 7

Trades before a print in RECURSION PHARMACEUTICALS, INC. 3

Interval to RECURSION PHARMACEUTICALS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates RECURSION PHARMACEUTICALS, INC. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 27, 2023”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.